Injectables refer to drug delivery system which acts as an alternative to oral drugs. As injectables are rapidly inserted into the human body using a syringe, they bypass the first-pass metabolism. The global generic injectables market size is projected to grow by USD 49 billion from 2022 to 2028, registering a CAGR of 8.7 percent, according to a new report by Gen Consulting Company.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global generic injectables market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the generic injectables industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, route of administration, application, and region. The global market for generic injectables can be segmented by product: large molecule, small molecule. Generic injectables market is further segmented by route of administration: intravenous (IV) generic injectables, intramuscular (IM) generic injectables, subcutaneous (SC) generic injectables, others. Based on application, the generic injectables market is segmented into: oncology, infectious diseases, cardiology, diabetes, immunology, others. On the basis of region, the generic injectables market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW).
By product:
- large molecule
- small molecule
By route of administration:
- intravenous (IV) generic injectables
- intramuscular (IM) generic injectables
- subcutaneous (SC) generic injectables
- others
By application:
- oncology
- infectious diseases
- cardiology
- diabetes
- immunology
- others
By region:
- Asia Pacific
- Europe
- North America
- Rest of the World (RoW)
The global generic injectables market report offers detailed information on several market vendors, including AstraZeneca plc, Baxter International, Inc., Dr. Reddy's Laboratories Ltd., Fresenius SE & Co. KGaA, Hikma Pharmaceuticals plc, Lupin Limited, Merck & Co., Inc., Mylan N.V., Pfizer, Inc, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
- To analyze and forecast the market size of the global generic injectables market.
- To classify and forecast the global generic injectables market based on product, route of administration, application, region.
- To identify drivers and challenges for the global generic injectables market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global generic injectables market.
- To identify and analyze the profile of leading players operating in the global generic injectables market.
Why Choose This Report
- Gain a reliable outlook of the global generic injectables market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
· Report description
· Objectives of the study
· Market segment
· Years considered for the report
· Currency
· Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
· Introduction
· Drivers
· Restraints
· Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY PRODUCT
· Large molecule
· Small molecule
PART 6. MARKET BREAKDOWN BY ROUTE OF ADMINISTRATION
· Intravenous (IV) generic injectables
· Intramuscular (IM) generic injectables
· Subcutaneous (SC) generic injectables
· Others
PART 7. MARKET BREAKDOWN BY APPLICATION
· Oncology
· Infectious diseases
· Cardiology
· Diabetes
· Immunology
· Others
PART 8. MARKET BREAKDOWN BY REGION
· Asia Pacific
· Europe
· North America
· Rest of the World (RoW)
PART 9. KEY COMPANIES
· AstraZeneca plc
· Baxter International, Inc.
· Dr. Reddy's Laboratories Ltd.
· Fresenius SE & Co. KGaA
· Hikma Pharmaceuticals plc
· Lupin Limited
· Merck & Co., Inc.
· Mylan N.V.
· Pfizer, Inc
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
Overview of the Global Generic Drug CRO (Contract Research Organisation) Market:
The report discusses everything a marketer requires before investing in the global Generic Drug CRO (Contract Research Organisation) M...
The global Generic Allergy Medicine market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in ...
The global Intravitreal (IVT) Injectables market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market playe...
Overview of the Global Generic Drug API Intermediates Solutions Market:
The report discusses everything a marketer requires before investing in the global Generic Drug API Intermediates Solutions Market during the f...
Overview of the Global Generic API Intermediates CDMO Services Market:
The report discusses everything a marketer requires before investing in the global Generic API Intermediates CDMO Services Market during the for...
Overview of the Global Generic Drug Consistency Evaluation Service Market:
The report discusses everything a marketer requires before investing in the global Generic Drug Consistency Evaluation Service Market during...
Overview of the Global Generic Drug Research and Development Services Market:
The report discusses everything a marketer requires before investing in the global Generic Drug Research and Development Services Market ...
Overview of the Global Generic Drug Intermediates CDMO Services Market:
The report discusses everything a marketer requires before investing in the global Generic Drug Intermediates CDMO Services Market during the f...
Overview of the Global Generic and Biosimilar Pharmaceuticals Market:
The report discusses everything a marketer requires before investing in the global Generic and Biosimilar Pharmaceuticals Market during the forec...
Overview of the Global Generic Oncology Sterile Injectable Market:
The report discusses everything a marketer requires before investing in the global Generic Oncology Sterile Injectable Market during the forecast pe...